Restatement of Previously Issued Financial Statements - Summary of Effect of the Restatement on Each Financial Statement Line Items as on Dates and Period Wise (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2020	Nov. 13, 2020	Jul. 07, 2020
Prior Period Restatement Of Consolidated Balance Sheet [Abstract]
Warrant liabilities	$ 47,516,962		$ 47,516,962
Total liabilities	56,785,987		56,785,987
Additional paid-in capital	39,627,462		39,627,462
Accumulated deficit/ Retained Deficit	(34,628,699)		(34,628,699)
Total stockholders' equity	5,000,006	$ 24,554	5,000,006	$ 0	$ 0
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Formation and operating costs	1,040,231		1,040,677
Changes in fair value of warrant liabilities	(33,607,289)		(33,607,289)
Other income (expense), net	(33,588,022)		(33,588,022)
Net loss	(34,628,253)	(446)	(34,628,699)
Cash Flows from Operating Activities:
Net loss	(34,628,253)	$ (446)	(34,628,699)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ 33,607,289		33,607,289
Non-Cash Investing and Financing Activities:
Initial measurement of warrants issued in connection with the Initial Public Offering accounted for as liabilities			$ 13,909,673
Common Stock Subject to Non Redeemable [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	7,686,824		6,992,903
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ (4.51)		$ (4.95)
As Previously Reported [Member]
Prior Period Restatement Of Consolidated Balance Sheet [Abstract]
Warrant liabilities	$ 0		$ 0
Total liabilities	$ 9,269,025		$ 9,269,025
Class A ordinary shares subject to possible redemption	241,263,980		241,263,980
Class A ordinary shares	131		131
Additional paid-in capital	$ 5,509,476		$ 5,509,476
Accumulated deficit/ Retained Deficit	(510,233)		(510,233)
Total stockholders' equity	5,000,010		5,000,010
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Formation and operating costs	529,054		529,500
Changes in fair value of warrant liabilities	0		0
Other income (expense), net	19,267		19,267
Net loss	$ (509,787)		$ (510,233)
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ (0.07)		$ (0.08)
Prior Period Restatement Of Condensed Consolidated Statement Of Changes In Stockholders Equity [Abstract]
Issuance of Class A ordinary shares, net of underwriting discounts and offering costs			$ 239,912,223
Proceeds in excess of fair value upon the sale of Private Warrants			6,837,000
Cash Flows from Operating Activities:
Net loss	$ (509,787)		(510,233)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ 0		0
Non-Cash Investing and Financing Activities:
Initial measurement of warrants issued in connection with the Initial Public Offering accounted for as liabilities			$ 0
As Previously Reported [Member] | Common Stock Subject to Mandatory Redemption [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	24,126,398		24,126,398
As Previously Reported [Member] | Common Stock Subject to Non Redeemable [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	6,948,070		6,614,900
Adjustment [Member]
Prior Period Restatement Of Consolidated Balance Sheet [Abstract]
Warrant liabilities	$ 47,516,962		$ 47,516,962
Total liabilities	$ 47,516,962		$ 47,516,962
Class A ordinary shares subject to possible redemption	(47,516,958)		(47,516,958)
Class A ordinary shares	476		476
Additional paid-in capital	$ 34,117,986		$ 34,117,986
Accumulated deficit/ Retained Deficit	(34,118,466)		(34,118,466)
Total stockholders' equity	(4)		(4)
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Formation and operating costs	511,177		511,177
Changes in fair value of warrant liabilities	(33,607,289)		(33,607,289)
Other income (expense), net	(33,607,289)		(33,607,289)
Net loss	$ (34,118,466)		$ (34,118,466)
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ (4.44)		$ (4.87)
Prior Period Restatement Of Condensed Consolidated Statement Of Changes In Stockholders Equity [Abstract]
Issuance of Class A ordinary shares, net of underwriting discounts and offering costs			$ (8,475,856)
Proceeds in excess of fair value upon the sale of Private Warrants			(4,922,640)
Cash Flows from Operating Activities:
Net loss	$ (34,118,466)		(34,118,466)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ 33,607,289		33,607,289
Non-Cash Investing and Financing Activities:
Initial measurement of warrants issued in connection with the Initial Public Offering accounted for as liabilities			$ 13,909,673
Adjustment [Member] | Common Stock Subject to Mandatory Redemption [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	(4,751,696)		(4,751,696)
Adjustment [Member] | Common Stock Subject to Non Redeemable [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	723,136		378,003
As Restated [Member]
Prior Period Restatement Of Consolidated Balance Sheet [Abstract]
Warrant liabilities	$ 47,516,962		$ 47,516,962
Total liabilities	$ 56,785,987		$ 56,785,987
Class A ordinary shares subject to possible redemption	193,747,022		193,747,022
Class A ordinary shares	607		607
Additional paid-in capital	$ 39,627,462		$ 39,627,462
Accumulated deficit/ Retained Deficit	(34,628,699)		(34,628,699)
Total stockholders' equity	5,000,006		5,000,006	$ 0
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Formation and operating costs	1,040,231		1,040,677
Changes in fair value of warrant liabilities	(33,607,289)		(33,607,289)
Other income (expense), net	(33,588,022)		(33,588,022)
Net loss	$ (34,628,253)		$ (34,628,699)
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ (4.51)		$ (4.95)
Prior Period Restatement Of Condensed Consolidated Statement Of Changes In Stockholders Equity [Abstract]
Issuance of Class A ordinary shares, net of underwriting discounts and offering costs			$ 231,436,367
Proceeds in excess of fair value upon the sale of Private Warrants			1,914,360
Cash Flows from Operating Activities:
Net loss	$ (34,628,253)		(34,628,699)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ 33,607,289		33,607,289
Non-Cash Investing and Financing Activities:
Initial measurement of warrants issued in connection with the Initial Public Offering accounted for as liabilities			$ 13,909,673
As Restated [Member] | Common Stock Subject to Mandatory Redemption [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	19,374,702		19,374,702
As Restated [Member] | Common Stock Subject to Non Redeemable [Member]
Prior Period Adjustment Restatement of Consolidated Statement Of Operations [Abstract]
Basic and diluted weighted average shares outstanding	7,671,206		6,992,903